Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Judge: Agency Could Have Stopped Exeter Hepatitis C Outbreak

A judge said a medical staffing agency could have stopped a hepatitis C outbreak that infected 32 Exeter Hospital patients.

Published
30 January 2013
From
Patch.com
Spanish research shows that liver stiffness can predict outcomes in people co-infected with HIV and hepatitis C

Liver stiffness is a strong predictor of hepatic complications and all-cause mortality in people co-infected with HIV and hepatitis C virus (HCV), Spanish investigators report in the

Published
30 January 2013
By
Michael Carter
Hepatitis C progress in pipeline: New drugs to treat virus expected be available in 2014-15

For more on this rapidly changing landscape, we turned to Dr. Donald M. Jensen, director of the Center for Liver Diseases at University of Chicago Medicine and a noted hepatitis C researcher, with more than 100 peer-reviewed articles.

Published
29 January 2013
From
Chicago Tribune
Phase II all-oral combination studies of simeprevir, TMC647055 and IDX719 for the treatment of hepatitis C to be initiated shortly

The collaboration will evaluate combinations including simeprevir (TMC435), a once-daily protease inhibitor jointly developed by Janssen R&D Ireland and Medivir, TMC647055, a potent once daily NNI (non-nucleoside inhibitor) of the HCV polymerase, boosted with low dose ritonavir, being developed by Janssen and IDX719, Idenix’s once-daily pan-genotypic NS5A inhibitor.

Published
29 January 2013
From
Medivir press release
The Age-Old Debate of Whether to Biopsy in HCV: My Answer for 2013

Mark Sulkowski MD discusses the role of liver biopsy in the management of the HCV patient.

Published
25 January 2013
From
Clinical Care Options (requires registration)
Hepatitis C linked to ink

Researchers are hoping that people will do some research about where to get a tattoo, after a study found a link between body art and hepatitis C.

Published
25 January 2013
From
Reuters
Support Inclusion of Pegylated Interferon in the World Health Organization’s Essential Medicines List

Civil-society groups have an important but limited opportunity to advocate for the inclusion of pegylated interferon on the World Health Organization Essential Medicines List. Deadline Mid-February!

Published
23 January 2013
From
Treatment Action Group
New ways to study HCV, genotypes 3 and 4

Researchers can now study replication of Hepatitis C virus genotypes 3 and 4 in cultured cells, described in 2 articles in the January issue of Gastroenterology. These new tools will improve our understanding of how they cause liver disease, and could lead to new treatments.

Published
22 January 2013
From
AGA Journals blog
Rapid pace of liver damage in recent HCV co-infection

The research suggests that HIV-positive people who later become co-infected with HCV are at risk for an accelerated pace of liver damage, perhaps caused by underlying immunological dysfunction.

Published
21 January 2013
From
CATIE
Copy of Rapid pace of liver damage in recent HCV co-infection

The research suggests that HIV-positive people who later become co-infected with HCV are at risk for an accelerated pace of liver damage, perhaps caused by underlying immunological dysfunction.

Published
21 January 2013
From
CATIE

Filter by country